UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 141

Sortiert nach

Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer

European urology, 2015-07, Vol.68 (1), p.139-146

2015

Link zum Volltext

Verfügbarkeit prüfen

Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer

Prostate cancer and prostatic diseases, 2018-04, Vol.21 (1), p.57-63

2018

Link zum Volltext

Verfügbarkeit prüfen

The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential

European urology, 2018-08, Vol.74 (2), p.204-210

2018

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study

Value in health, 2021-12, Vol.24 (12), p.1763-1772

2021

Link zum Volltext

Verfügbarkeit prüfen

The risk of prostate cancer for men on aspirin, statin or antidiabetic medications

European journal of cancer (1990), 2015-04, Vol.51 (6), p.725-733

2015

Link zum Volltext

Verfügbarkeit prüfen

Prostate Age Gap: An MRI Surrogate Marker of Aging for Prostate Cancer Detection

Journal of magnetic resonance imaging, 2023-10

2023

Link zum Volltext

Verfügbarkeit prüfen

Towards Next-generation Urine-based Prostate Cancer Risk Stratification

European urology, 2018-12, Vol.74 (6), p.739-740

2018

Link zum Volltext

Verfügbarkeit prüfen

Repeat Prostate-Specific Antigen Tests Before Prostate Biopsy Decisions

JNCI : Journal of the National Cancer Institute, 2016-12, Vol.108 (12), p.djw165

2016

Link zum Volltext

Verfügbarkeit prüfen

Prostate-specific Antigen (PSA) Testing Is Prevalent and Increasing in Stockholm County, Sweden, Despite No Recommendations for PSA Screening: Results from a Population-based Study, 2003–2011

European urology, 2013-03, Vol.63 (3), p.419-425

2013

Link zum Volltext

Verfügbarkeit prüfen

Incorporating Magnetic Resonance Imaging and Biomarkers in Active Surveillance Protocols - Results From the Prospective Stockholm3 Active Surveillance Trial (STHLM3AS)

JNCI : Journal of the National Cancer Institute, 2021-05, Vol.113 (5), p.632-640

2021

Link zum Volltext

Verfügbarkeit prüfen

Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality

JAMA oncology, 2022-07, Vol.8 (7), p.1019

2022

Link zum Volltext

Verfügbarkeit prüfen

Association between PSA density and prostate cancer in men without significant MRI lesions

BJU international, 2020-06, Vol.125 (6), p.763-764

2020

Link zum Volltext

Verfügbarkeit prüfen

Reply to Erik Rud, Peter Lauritzen, and Eduard Baco's Letter to the Editor re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol 2018;74:722–8

European urology, 2019-04, Vol.75 (4), p.e104-e105

2019

Link zum Volltext

Verfügbarkeit prüfen

Reducing private car demand, fact or fiction? A study mapping changes in accessibility to grocery stores in Norway

European transport research review, 2021, Vol.13 (1), p.39-39, Article 39

2021

Link zum Volltext

Verfügbarkeit prüfen

Reply to Ola Bratt and Anna Öfverholm's Letter to the Editor re: Peter Ström, Tobias Nordström, Henrik Grönberg, Martin Eklund. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.12.028

European urology, 2018-07, Vol.74 (1), p.e10-e11

2018

Link zum Volltext

Verfügbarkeit prüfen

A Genetic Score Can Identify Men at High Risk for Prostate Cancer Among Men With Prostate-Specific Antigen of 1–3 ng/ml

European urology, 2014-06, Vol.65 (6), p.1184-1190

2014

Link zum Volltext

Verfügbarkeit prüfen

The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort

Prostate cancer and prostatic diseases, 2019-03, Vol.22 (1), p.137-142

2019

Link zum Volltext

Verfügbarkeit prüfen

Re: Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol 2015;68:139–46

European urology, 2018-08, Vol.74 (2), p.e35-e36

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies

World journal of urology, 2021-04, Vol.39 (4), p.1153-1159

2021

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer

Nature communications, 2017-01, Vol.8 (1), p.14248-14248, Article 14248

2017

Link zum Volltext

Verfügbarkeit prüfen

MRI-Targeted or Standard Biopsy in Prostate Cancer Screening

The New England journal of medicine, 2021-09, Vol.385 (10), p.908-920

2021

Link zum Volltext

Verfügbarkeit prüfen

External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort

European urology focus, 2023-05, Vol.9 (3), p.455-462

2023

Link zum Volltext

Verfügbarkeit prüfen

Future directions in prostate cancer testing: a comment upon results from the prospective population-based diagnostic STHLM3 study—Grönberg H et al. Lancet Oncology. 2015 Nov 9; doi:10.1016/S1470-2045(15)00361-7

World journal of urology, 2017-06, Vol.35 (6), p.895-896

2017

Link zum Volltext

Verfügbarkeit prüfen

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

The lancet oncology, 2015-12, Vol.16 (16), p.1667-1676

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(137)
Mit Volltextzugriff
(121)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer

Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer

The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential

Cost-Effectiveness of Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study

The risk of prostate cancer for men on aspirin, statin or antidiabetic medications

Prostate Age Gap: An MRI Surrogate Marker of Aging for Prostate Cancer Detection

Towards Next-generation Urine-based Prostate Cancer Risk Stratification

Repeat Prostate-Specific Antigen Tests Before Prostate Biopsy Decisions

Prostate-specific Antigen (PSA) Testing Is Prevalent and Increasing in Stockholm County, Sweden, Despite No Recommendations for PSA Screening: Results from a Population-based Study, 2003–2011

Incorporating Magnetic Resonance Imaging and Biomarkers in Active Surveillance Protocols - Results From the Prospective Stockholm3 Active Surveillance Trial (STHLM3AS)

Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality

Association between PSA density and prostate cancer in men without significant MRI lesions

Reply to Erik Rud, Peter Lauritzen, and Eduard Baco's Letter to the Editor re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol 2018;74:722–8

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis

Reducing private car demand, fact or fiction? A study mapping changes in accessibility to grocery stores in Norway

A Genetic Score Can Identify Men at High Risk for Prostate Cancer Among Men With Prostate-Specific Antigen of 1–3 ng/ml

The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort

Re: Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol 2015;68:139–46

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies

Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer

MRI-Targeted or Standard Biopsy in Prostate Cancer Screening

External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort

Future directions in prostate cancer testing: a comment upon results from the prospective population-based diagnostic STHLM3 study—Grönberg H et al. Lancet Oncology. 2015 Nov 9; doi:10.1016/S1470-2045(15)00361-7

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

Suchergebnisse filtern